BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1224 related articles for article (PubMed ID: 15930183)

  • 1. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor.
    Gilad LA; Schwartz B
    J Mol Endocrinol; 2007 Jun; 38(6):603-18. PubMed ID: 17556531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells.
    Gilad LA; Tirosh O; Schwartz B
    J Endocrinol; 2006 Nov; 191(2):387-98. PubMed ID: 17088408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of MAPK ERK1 and ERK2 in VDR-positive and -negative breast cancer cell lines.
    Cordes T; Diesing D; Becker S; Diedrich K; Reichrath J; Friedrich M
    Anticancer Res; 2006; 26(4A):2749-53. PubMed ID: 16886687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ; Brown G
    J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
    Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells.
    Muscella A; Greco S; Elia MG; Storelli C; Marsigliante S
    J Cell Physiol; 2003 Oct; 197(1):61-8. PubMed ID: 12942541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor.
    Smirnoff P; Liel Y; Gnainsky J; Shany S; Schwartz B
    Oncol Res; 1999; 11(6):255-64. PubMed ID: 10691027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17beta-estradiol induces the translocation of the estrogen receptors ESR1 and ESR2 to the cell membrane, MAPK3/1 phosphorylation and proliferation of cultured immature rat Sertoli cells.
    Lucas TF; Siu ER; Esteves CA; Monteiro HP; Oliveira CA; Porto CS; Lazari MF
    Biol Reprod; 2008 Jan; 78(1):101-14. PubMed ID: 17928626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
    Lee M
    Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
    Ahmed KM; Dong S; Fan M; Li JJ
    Mol Cancer Res; 2006 Dec; 4(12):945-55. PubMed ID: 17189385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.